http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2365380-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7498627718b5930d6363f1ee10906101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94051de71c6747e27639e1be68097d4b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| filingDate | 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7bd2e8ae169ba1dbccf152ac442765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de1a1aea16c9de1a1d7a8e6bf27e12d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8725ce5dcb438f8194b783a893a28c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8482fd6211989dd7f54e16d6c072465f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be5b60328fce0ec239c3368db43df382 |
| publicationDate | 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2365380-C1 |
| titleOfInvention | Method of acute myocardial infarction treatment |
| abstract | FIELD: medicine. n SUBSTANCE: invention concerns medicine, namely to cardiology. The puncture of a femoral artery under local anaesthesia and medicamnetla sedation, selective catheterisation and coronarography of a coronary artery, installation of a guiding catheter in a mouth of the damaged coronary artery, performance of a balloon angioplasty of a stenosis place or occlusion of a coronary artery under the roentgenoscopy and coronarography control and medical product administration is carried out. Thus the coronary intravascular prosthesis - a stent is implanted into a stenosis or occlusion place after balloon angioplasty under the roentgenoscopy and coronarography control. Then a medical product in the form of a single eptifibatide dose in amount of 20 mg, dissolved in a 0.9% sodium chloride solution to 1 mg/ml concentration with rate of 4 mg/min within 5 minutes with the subsequent intravenous eptifibatide administration in amount of 2 mkg a minute on each kg of body mass of the patient within 12 hours is entered through a guiding catheter immediately into a mouth of the damaged coronary artery. n EFFECT: restoration normal coronary blood flow level in an Infarct-dependent coronary artery. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2702146-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2456934-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2695341-C1 |
| priorityDate | 2008-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.